SCHEMBL650148

SCHEMBL650148

CCCCn1c(-c2ccccc2)nc(Cl)c1CN(Cc1ccc(OC(C)=O)c(C)c1)Cc1ccc2c(c1)OCCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.48
TSHR P16473 1/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPK1 P28482 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PPARG P37231 3/20 0.35
PPARA Q07869 3/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 1/20 0.35
GAA P10253 1/20 0.35
KCNH2 Q12809 1/20 0.35
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650146 0.91 C5AR1 (0.51) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL651031 0.90 C5AR1 (0.48) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL651208 0.90 C5AR1 (0.49) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL648948 0.89 C5AR1 (0.50) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL652376 0.89 C5AR1 (0.58) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL1913084 0.88 C5AR1 (0.51) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL649353 0.87 C5AR1 (0.49) C5AR1PTGDR2CYP2C8CYP2C9CYP2C19
SCHEMBL648636 0.87 C5AR1 (0.51) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL650147 0.87 C5AR1 (0.51) C5AR1TSHRPTGDR2CYP2C8CYP2C9
SCHEMBL1912840 0.86 C5AR1 (0.63) C5AR1TSHRALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed